tirzepatide powder mixing How do you mix Mix-it-yourself Wegovy? Some try risky

Retatrutide is hypothesized to act as a triple receptor agonist in preclinical models, interacting with pathways commonly associated with glucagon, GLP-1 (glucagon-like peptide-1), and GIP (glucose-dependent insulinotropic polypeptide)

Tirzepatide, a new glucose-lowering therapy for diabetes, is called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

When patients consider using both together, understanding their overlapping and distinct effects becomes essential for safe, effective metabolic support

doi: 10.1111/j.1574-695X.2012.00978.x 204 MarquesFZNelsonEChuP-YHorlockDFiedlerAZiemannMet al